Literature DB >> 7513352

The observation of angiogenin and basic fibroblast growth factor gene expression in human colonic adenocarcinomas, gastric adenocarcinomas, and hepatocellular carcinomas.

D Li1, J Bell, A Brown, C L Berry.   

Abstract

Using digoxigenin-labelled, synthetic oligonucleotide probe cocktails of angiogenin and bFGF genes, the expression of the two genes was observed by in situ hybridization in ten colonic adenocarcinomas, seven gastric adenocarcinomas, and four hepatocellular carcinomas. The angiogenin gene was expressed in eight of the ten cases of colonic adenocarcinoma and in all of the four cases where dysplastic glands were found. Angiogenin expression was evident in four of the seven cases of gastric adenocarcinoma. bFGF expression was detected in only five of the seven gastric carcinoma cases. The mRNAs for angiogenin and bFGF were mainly cytoplasmic in distribution and were only occasionally seen in the nuclei of the positive cells. Neither the angiogenin gene mRNA nor the bFGF mRNA was expressed in the four cases of hepatocellular carcinoma. It is postulated that the angiogenin gene may play an important role in angiogenesis in colonic adenocarcinomas; in gastric cancers, both angiogenin and bFGF were involved in this process. For hepatocellular carcinomas, neither angiogenin nor bFGF production appeared to be related to angiogenesis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7513352     DOI: 10.1002/path.1711720203

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  14 in total

1.  Mechanism and Function of Angiogenin in Hematopoietic Malignancy.

Authors:  Kevin A Goncalves; Guo-Fu Hu
Journal:  Zhongguo Sheng Wu Hua Xue Yu Fen Zi Sheng Wu Xue Bao       Date:  2015-12-23

2.  A therapeutic target for prostate cancer based on angiogenin-stimulated angiogenesis and cancer cell proliferation.

Authors:  Norie Yoshioka; Li Wang; Koji Kishimoto; Takanori Tsuji; Guo-fu Hu
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-13       Impact factor: 11.205

3.  A quantitative investigation of immunocytochemically stained blood vessels in normal, benign, premalignant and malignant human oral cheek epithelium.

Authors:  Y Jin; G L Tipoe; F H White; L Yang
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

4.  Evaluation of laser doppler flowmetry for the study of benign and malignant gastric blood flow in vivo.

Authors:  M K Schilling; C Redaelli; H Friess; B Blum; C Signer; C A Maurer; M W Büchler
Journal:  Gut       Date:  1999-09       Impact factor: 23.059

Review 5.  Angiogenin-mediated ribosomal RNA transcription as a molecular target for treatment of head and neck squamous cell carcinoma.

Authors:  Lili Chen; Guo-fu Hu
Journal:  Oral Oncol       Date:  2010-07-24       Impact factor: 5.337

6.  Expression of fibroblast growth factor-1 and fibroblast growth factor-2 in normal liver and hepatocellular carcinoma.

Authors:  N H Chow; K S Cheng; P W Lin; S H Chan; W C Su; Y N Sun; X Z Lin
Journal:  Dig Dis Sci       Date:  1998-10       Impact factor: 3.199

7.  Neomycin inhibits angiogenin-induced angiogenesis.

Authors:  G F Hu
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-18       Impact factor: 11.205

8.  Microarray analysis of somatostatin receptor 5-regulated gene expression profiles in murine pancreas.

Authors:  Sanjeet G Patel; Guisheng Zhou; Shi-He Liu; Min Li; Jae-Wook Jeong; Francesco J DeMayo; Marie-Claude Gingras; Richard A Gibbs; William E Fisher; F Charles Brunicardi
Journal:  World J Surg       Date:  2009-04       Impact factor: 3.352

9.  A small-molecule inhibitor of the ribonucleolytic activity of human angiogenin that possesses antitumor activity.

Authors:  Richard Y T Kao; Jeremy L Jenkins; Karen A Olson; Marc E Key; James W Fett; Robert Shapiro
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-12       Impact factor: 11.205

10.  FGF-18, a novel member of the fibroblast growth factor family, stimulates hepatic and intestinal proliferation.

Authors:  M C Hu; W R Qiu; Y P Wang; D Hill; B D Ring; S Scully; B Bolon; M DeRose; R Luethy; W S Simonet; T Arakawa; D M Danilenko
Journal:  Mol Cell Biol       Date:  1998-10       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.